• Treczoks@lemmy.world
    link
    fedilink
    English
    arrow-up
    1
    arrow-down
    1
    ·
    11 days ago

    Theoretically, this could approved in Europe, which is fine for me. But I doubt the pharmaceutical industry will let a working, permanent immunisation against the common cold happen. That would mean billions and trillions of lost business.

    • Supervisor194@lemmy.world
      link
      fedilink
      English
      arrow-up
      1
      ·
      11 days ago

      I never understand it when this argument is made. It assumes that there aren’t entities out there making $0 on the common cold that would refuse to take the absolute fucking windfall that would be generated if such an immunization were to be brought to the market.

      Like “oh, you know, we’d like to make this immunization and make billions of dollars ourselves but these OTHER guys are already making billions of dollars and we sure wouldn’t want to step on their toes.”

    • Ledericas@lemm.ee
      link
      fedilink
      English
      arrow-up
      0
      ·
      10 days ago

      its pretty hard to vaccinate against the common cold, since coronavirus only represents like 15ish percent, the majority are all rhinoviruses there arnt any vaccines for those because theres too many strains(like 200+) to deal with, and also its so self-limiting its not worht it to produce anyway, in addition to trying to figure out which virus is causing the cold and which strain. also there a bunch of other viruses that causes colds, like entero,adeno, parainfluenza, RSV,etc.

      • Treczoks@lemmy.world
        link
        fedilink
        English
        arrow-up
        1
        ·
        10 days ago

        I’m well aware of that, but taking only 15% out of a multi-billion-a-year market is still money. And there has been research into dealing with rhinoviruses in general, too, so that would take an even larger chunk.